Jupiter Life Line Hospitals Share Price

Jupiter Life Line Hospitals Limited was incorporated in Mumbai, Maharashtra through a Certificate of Incorporation dated November 18, 2002, issued by the RoC, which subsequently, commenced its business operations in December, 2002. Led by founding Promoter, Dr. Ajay Thakker, the Company is a prominent multispeciality tertiary and quaternary healthcare service provider in the Mumbai metropolitan area and Western India with total operational bed capacity of 1,194 across three hospitals located in Thane, Pune and Indore under the Jupiter brand. The Company is constructing a new multispeciality hospital in Dombivali, Maharashtra with potential capacity of 500 beds. The Company is also running Fortune Park Lake City Hotel in Thane for promoting medical tourism. The Company follow a patient first ideology by creating the best infrastructure, technology and support to put the patient first and foremost and be futuristic and innovative in delivery of healthcare. It serve the healthcare needs of patients and hospitals equipped hospitals with over 30 specialties, including key specialties of organ transplant, oncology, orthopaedics, cardiology, paediatrics, neurology and neurosurgery as well as certain specialized quaternary services and precisionbased treatments such as brachytherapy, radiotherapy, robotic knee replacement and robotic neuro rehabilitation.The Company commenced its business in December, 2002. It started operations at Thane hospital, Maharashtra in 2007. Later, it scaled operations by setting up a hospital in Pune in 2017. The Company carried out interstitial brachytherapy to treat cancer in Thane Hospital in 2018. In 2020, it acquired the Indore Hospital in Madhya Pradesh. In 2021, the Company carried out small bowel intestine transplant surgery at Thane Hospital and heart transplant surgery at Thane Hospital in 2022. In September 2023, Company made an IPO of 11,824,163 Equity Shares by raising funds aggregating to Rs 869 Crore comprising a Fresh Issue of 7,374,163 Equity Shares aggregating to Rs 542 Crore and an Offer for Sale of 4,450,000 Equity Shares aggregating to Rs 327 Crore.The Company added 22 beds in Pune and 78 beds in Indore, along with commissioning a new 11bed ICU in FY 25. By deconstructinga 22bed unit, it created room for two additional operating theatres, a second MRI machine, a second cath lab, expanded Daycare andChemotherapy Suites, and a new OPD cluster.

Jupiter Life Line Hospitals reported a Q2 FY 2025-26 revenue of ₹393.63 crore, up 17.8% YoY, with net profit increased 9.6% to ₹57.48 crore. For the full year FY2025–2026, revenue reached ₹1290.22 crore and profit touched at ₹193.5 crore. As of Sep '25, Jupiter Life Line Hospitals’s market capitalisation stood at ₹9,666.40 crores. Shareholding as of Sep '25 shows promoters holding 40.9%, with FIIs at 9.1%, DIIs at 16.9%, and public at 33.1%.

As of 1 Dec 2025, Jupiter Life Line Hospitals share price is ₹1474.3. The stock opened at ₹1460.5 and had closed at ₹1480.1 the previous day. During today’s trading session, Jupiter Life Line Hospitals share price moved between ₹1,460.50 and ₹1,491.30, with an average price for the day of ₹1475.90. Over the last 52 weeks, the stock has recorded a low of ₹1,266.00 and a high of ₹1,770.00. In terms of performance, Jupiter Life Line Hospitals share price has increased by 0.6% over the past six months and has increased by 7.85% over the last year.